Delivery Order SPE2DB22D2206-SPE2DB24FFK06
- Not listed
- This federal contract award, valued at $30,713.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500-count bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The contract has a completion date of February 7, 2024 and is a firm fixed-price delivery order. No set-aside designation was applied. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.41 firm fixed-price delivery order is for the supply of 500 units of Bupropion HCL XL 150 mg tablets, a medication used for the treatment of depression and other mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of bupropion HCL XL 300 mg tablets, a medication used to treat depression. The award has a ceiling value of $1,951.17 and is a firm fixed price delivery order contract with a completion date of November 30, 2023. The contract is not designated as a set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The $1,647.38 firm-fixed-price delivery order is for the supply of 4,566,120 units of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression and smoking cessation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.38 firm fixed-price contract is for the supply of Bupropion HCL XL 150 mg tablets, a generic drug used to treat depression and other conditions. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a generic pharmaceutical product used to treat depression and other conditions. The contract has a ceiling value of $60,554.02 and is structured as a Firm Fixed Price delivery order, with a period of performance ending on April 30, 2024. This contract award...
- This federal contract award, valued at $2,537.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and other conditions. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $4,176.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,502,725 units of Bupropion HCL XL 300 mg tablets, a medication used to treat depression. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX9DV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and other conditions. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $21,578.51 and a completion date of January 23, 2024. It is not...
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets, which are prescribed for the treatment of depression and other mental health conditions. The contract, valued at $3,837.38, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999 and running through...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFK06Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,688.03, is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.7k | 1/31/24 |